Exelixis Inc

2026-10-09 20:06; UTC

RBC Capital raised its price target on Exelixis Inc to $51 while maintaining a Sector Perform rating, coinciding with the stock's positive performance.

2026-10-08 20:07; UTC

Exelixis Inc's shares advanced, supported by broader market strength, maintaining an upward trajectory despite an earlier pullback from a session high.

2026-10-07 19:45; UTC

Exelixis Inc shares are trading higher as Truist Securities raises the price target to $54.00 from $52.00 while maintaining a Hold rating.

2026-10-06 21:01; UTC

Exelixis Inc is trading modestly lower in after-market hours, positioned around the midpoint of its one-month trading range.

2026-10-05 21:10; UTC

Exelixis Inc. is advancing in after-market trading, closing at its highest point of the day after three consecutive sessions of gains.

2026-10-02 20:00; UTC

Exelixis Inc shares are advancing, reaching a peak cumulative return and remaining well above their 20-day moving average during Friday's market session.

2026-10-01 20:07; UTC

Exelixis Inc's shares fell modestly, reflecting routine performance amid broader market conditions, and are currently near the low end of their daily range.

2026-09-30 23:20; UTC

Exelixis Inc shares are higher in after-market trading, continuing a five-day gain, supported by strong Q2 GDP growth despite mixed inflation and consumer spending signals.

2026-09-29 20:31; UTC

Exelixis Inc saw a significant decline in after-market trading, continuing a downward trend since Tuesday's close following earlier gains.

2026-09-28 19:16; UTC

Exelixis Inc is trading modestly higher, currently 2.25% above its 20-day moving average, reflecting routine activity for this time of day.

2026-09-25 23:20; UTC

Exelixis Inc is lower in after-market trading, retracing from an early gain and reflecting a decline since Friday's close.

2026-09-24 20:01; UTC

Exelixis Inc is advancing, peaking in mid-afternoon while remaining above its 20-day moving average and near the upper end of its one-month range.

2026-09-23 20:07; UTC

Exelixis Inc shares fell significantly on Wednesday, having briefly spiked earlier in the session, reflecting a lack of momentum in either direction.

2026-09-22 20:06; UTC

Exelixis Inc is gaining today, building on Monday's momentum, with the stock remaining above its 20-day moving average and near its one-month range's upper end.

2026-09-21 23:25; UTC

Exelixis Inc is trading modestly lower in after-market hours, continuing a decline seen over the past three sessions after reaching a session high.

2026-09-18 20:06; UTC

Exelixis Inc's shares fell sharply after reaching a notable peak earlier in the session, while remaining above the 20-day moving average.

2026-09-16 20:07; UTC

Exelixis Inc shares fell sharply, retracing from an early peak in cumulative return amid unusually high market volume on Wednesday.

2026-09-15 20:07; UTC

Exelixis Inc. shares are higher as the company expands CABOMETYX in renal cell carcinoma and neuroendocrine tumors, reflecting investor confidence amid broader market concerns.

2026-09-14 20:07; UTC

Exelixis shares are rising after BMO indicated the FDA's PDUFA date extension for Zanzalintinib is procedural, maintaining a $55 price target.

2026-09-11 20:01; UTC

Exelixis shares are lower as the FDA extends the review period for zanzalintinib by three months, now set for March 3, 2027.

2026-09-10 20:07; UTC

Exelixis Inc shares are lower amid market reaction to the European Central Bank's interest rate hike. The stock briefly recovered earlier in the session.

2026-09-09 20:07; UTC

Exelixis announced a $2 million milestone payment to Adagene for preclinical progress on the XB404 program, boosting shares in Wednesday's session.

2026-09-08 19:51; UTC

Exelixis Inc shares are lower today, influenced by a decline in the Biotechnology sub-sector, breaking a trend of higher daily closes since Friday.

2026-09-03 20:07; UTC

Exelixis Inc is advancing during Thursday's session, maintaining upward momentum since Wednesday. No specific news was identified to explain the price movement.

2026-09-02 23:56; UTC

Exelixis Inc shares are higher in after-market trading, though no specific news was identified. The broader market reacted to weaker ADP payroll data.

2026-09-01 23:06; UTC

Exelixis Inc. shares are lower in after-market hours, with no specific news identified for the decline amid broader market concerns.

2026-08-31 22:16; UTC

Exelixis shares are higher in after-market hours, rebounding from a slight dip earlier. This follows broader market reactions to Federal Reserve comments on inflation.

2026-08-28 23:01; UTC

Exelixis Inc shares are lower in after-market hours, continuing a trend of declines amid rising interest rate hike expectations affecting the biotechnology sector.

2026-08-27 20:07; UTC

Exelixis Inc shares are trading lower amid broader market declines. The cumulative return has reached a low point, with no specific news driving the movement.

2026-08-26 23:01; UTC

Exelixis Inc's shares are higher in after-market trading, reaching a high of 0.73% above Wednesday's close and 5.12% above its 20-day moving average.